ATE387207T1 - Zweifach coating-beschichteten milchsäurenbakterienpulver mit protein und polysaccharid und das verfahren zur deren herstellung sowie deren dosisform - Google Patents

Zweifach coating-beschichteten milchsäurenbakterienpulver mit protein und polysaccharid und das verfahren zur deren herstellung sowie deren dosisform

Info

Publication number
ATE387207T1
ATE387207T1 AT03255553T AT03255553T ATE387207T1 AT E387207 T1 ATE387207 T1 AT E387207T1 AT 03255553 T AT03255553 T AT 03255553T AT 03255553 T AT03255553 T AT 03255553T AT E387207 T1 ATE387207 T1 AT E387207T1
Authority
AT
Austria
Prior art keywords
lactic acid
acid bacteria
dosage form
polysaccharide
protein
Prior art date
Application number
AT03255553T
Other languages
English (en)
Inventor
Myung-Jun Chung
Young-Jai Cho
Soo-Dong Kim
Un-Pyoe Hong
Original Assignee
Myung-Jun Chung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myung-Jun Chung filed Critical Myung-Jun Chung
Application granted granted Critical
Publication of ATE387207T1 publication Critical patent/ATE387207T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04Preserving or maintaining viable microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/30Encapsulation of particles, e.g. foodstuff additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4875Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5052Proteins, e.g. albumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT03255553T 2003-09-05 2003-09-05 Zweifach coating-beschichteten milchsäurenbakterienpulver mit protein und polysaccharid und das verfahren zur deren herstellung sowie deren dosisform ATE387207T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03255553A EP1514553B1 (de) 2003-09-05 2003-09-05 Zweifach Coating-beschichteten Milchsäurenbakterienpulver mit Protein und Polysaccharid und das Verfahren zur deren Herstellung sowie deren Dosisform

Publications (1)

Publication Number Publication Date
ATE387207T1 true ATE387207T1 (de) 2008-03-15

Family

ID=34130343

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03255553T ATE387207T1 (de) 2003-09-05 2003-09-05 Zweifach coating-beschichteten milchsäurenbakterienpulver mit protein und polysaccharid und das verfahren zur deren herstellung sowie deren dosisform

Country Status (5)

Country Link
EP (1) EP1514553B1 (de)
AT (1) ATE387207T1 (de)
DE (1) DE60319375T2 (de)
DK (1) DK1514553T3 (de)
ES (1) ES2300546T3 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1884513B (zh) * 2006-06-23 2010-04-14 湖南科尔生物技术有限公司 益生菌双层包埋微囊工艺
CN107087706A (zh) * 2009-08-14 2017-08-25 杜邦营养生物科学有限公司 具有增强稳定性和生存力的包被的脱水微生物
FR2955774A1 (fr) 2010-02-02 2011-08-05 Aragan Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
EP2228067B1 (de) 2010-02-22 2013-12-11 LR Health & Beauty Systems GmbH Probiotische Zusammensetzung und deren Verwendung
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
BR112012024432A2 (pt) * 2010-03-29 2016-05-31 Ferring Bv composição farmacêutica de dissolução rápida
AU2013263795B2 (en) * 2010-03-29 2015-09-17 Ferring B.V. A fast dissolving pharmaceutical composition
ES2500046T3 (es) * 2010-08-10 2014-09-29 R.P. Scherer Technologies, Llc Proceso para la fabricación de una cápsula estable de gel blando que contiene bacterias probióticas microencapsuladas
NZ620897A (en) 2011-09-16 2016-07-29 Ferring Bv A fast dissolving pharmaceutical composition
FR2984352B1 (fr) * 2011-12-16 2018-02-16 Lesaffre Et Compagnie Composition comprenant une biomasse microbienne active
CN103571767B (zh) * 2012-07-26 2016-03-02 细胞生物技术公司 利用食用琼脂的双重涂布乳酸菌粉及其制备方法
AU2014357610B2 (en) * 2013-12-06 2017-10-12 Mjn U.S. Holdings Llc Probiotic stabilization
KR101589465B1 (ko) 2015-05-21 2016-02-01 주식회사 쎌바이오텍 성장 촉진을 위한 비피도박테리움 브레베 cbt br3 균주 및 이를 포함하는 성장촉진용 기능성 식품 조성물
AU2016353091B2 (en) * 2015-11-10 2022-07-14 Probiotech Llc Probiotic delivery systems
MX2018013760A (es) 2016-05-11 2019-03-21 Chr Hansen As Bacterias de acido lactico para producto alimenticio tratado con calor para almacenamiento a temperatura ambiente.
US11571387B2 (en) * 2017-03-27 2023-02-07 Praj Industries Limited Process for the preparation of powdered probiotic formulations for monogastric animals
US20190388344A1 (en) 2018-06-22 2019-12-26 Probiotech Llc Method to Improve The Health Of The Microbiome In A Human Gastrointestinal System and Multi-Chamber Probiotic Delivery Products Therefor
US20220304357A1 (en) 2019-09-12 2022-09-29 Chr. Hansen A/S Lactic acid bacteria for a heat-treated food product for storage at ambient temperature
US12453805B2 (en) 2020-09-24 2025-10-28 Everest Medical Innovation GmbH Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery
US12426594B2 (en) 2020-09-24 2025-09-30 Everest Medical Innovation GmbH Cryoprotective compositions and methods for protection of a surgical site during cryosurgery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1190386A (en) * 1966-06-28 1970-05-06 Green Cross Corp Process for producing the Lactic Acid Bacteria Drugs
US3677897A (en) * 1970-08-31 1972-07-18 George A Jeffreys Live lactic acid bacteria cultures and process of producing same
JPS60221078A (ja) * 1984-04-18 1985-11-05 Morinaga Milk Ind Co Ltd 有用微生物粉末の粒状製品およびその製造法
WO1997046224A1 (en) * 1996-06-06 1997-12-11 Bifodan A/S Enteric coating, comprising alginic acid, for an oral preparation
KR100387245B1 (ko) * 1997-10-17 2003-08-19 일양약품주식회사 유산균의안정화를위한미세장용성코팅과립
KR100429494B1 (ko) * 2001-02-28 2004-05-03 정명준 단백질 코팅 유산균의 제조방법

Also Published As

Publication number Publication date
DE60319375T2 (de) 2009-02-19
DE60319375D1 (de) 2008-04-10
ES2300546T3 (es) 2008-06-16
EP1514553B1 (de) 2008-02-27
EP1514553A1 (de) 2005-03-16
DK1514553T3 (da) 2008-06-23

Similar Documents

Publication Publication Date Title
ATE387207T1 (de) Zweifach coating-beschichteten milchsäurenbakterienpulver mit protein und polysaccharid und das verfahren zur deren herstellung sowie deren dosisform
MXPA03009840A (es) Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos.
TNSN05007A1 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof.
Kaur Biomedical, therapeutic and clinical applications of bioactive glasses
CN105176080A (zh) 一种生物相容性良好的可注射水凝胶及其制备方法和应用
EP3020397A3 (de) Verfahren zur herstellung von ajoen-derivaten
CN108078872A (zh) 天然低共熔溶剂作为防腐剂的应用
CN104224775A (zh) 一种包含四苯乙烯衍生物的药物组合物
CN113368054A (zh) 一种多聚脱氧核糖核苷酸柔性纳米脂质体的制备方法
EP1594885B8 (de) Medikament zur wachstumsinhibierung von tumoren
CN102226009A (zh) 一种交联透明质酸凝胶的制备方法
ATE440144T1 (de) Die verwendung von abc transporter kodierenden genen zur stimulierung der herstellung von sekundärmetaboliten in biologischen zellen
TW200740697A (en) Yttrium oxide composition, method of preparing the same, and method of forming yttrium oxide layer using the same
DE60100500D1 (de) Suspension enthaltend ein epi-hne protein, verfahren zu ihrer herstellung, daraus hergestelltes trockenpulveraerosol, arzneimittelzusammensetzungen enthaltend diese suspension oder dieses aerosol und ihre verwendungen
WO2018089368A4 (en) Bacteriocin production, compositions and methods of use
CN107290200A (zh) 一种磷酸盐缓冲液及其制备方法
DE502005008351D1 (de) Chinolinderivat, dessen verwendung, herstellung und dieses enthaltendes arzneimittel
WO2009093872A3 (ko) 신규한 디아민 화합물 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 포함하는 암 치료용 약학 조성물
CN101129298A (zh) 净纯牙膏
CN104784103A (zh) 基于寡聚氨基酸两亲分子可注射抗菌水凝胶
CN104450506B (zh) 厌氧血培养基、培养瓶及培养瓶的制备方法
MY160005A (en) 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt
CN108864444B (zh) 一种水凝胶及其制备方法
WO2012015226A3 (en) Fabrication method of a novel artificial cortical bone using a multi-pass extrusion process
PL1651592T3 (pl) Nowe dibenzo[b,f]oksepino-10-karboksyamidy i ich zastosowania farmaceutyczne

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties